Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arseny J. Gayduk"'
Autor:
Timur S. Syunyakov, Alexey V. Pavlichenko, Petr V. Morozov, Ilya A. Fedotov, Viktoriia E. Filatova, Arseny J. Gayduk, Yulia S. Ignatenko, Anna A. Spikina, Anna A. Yashikhina, Mikaella E. Patsali, Konstantinos N. Fountoulakis, Daria A. Smirnova
Publikováno v:
Consortium Psychiatricum, Vol 3, Iss 2, Pp 15-36 (2022)
BACKGROUND: Suicidality is a complex clinical phenomenon reflecting vulnerability to suicidal behavior which can be explained via the biopsychosocial paradigm and in relationship with a variety of country-specific factors. Data on suicides within the
Externí odkaz:
https://doaj.org/article/cf345e8d32ae472a9be4cf5ab8465440
Autor:
Elena E. Vaiman, Natalia A. Shnayder, Aiperi K. Khasanova, Anna I. Strelnik, Arseny J. Gayduk, Mustafa Al-Zamil, Margarita R. Sapronova, Natalia G. Zhukova, Daria A. Smirnova, Regina F. Nasyrova
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 2010 (2022)
Among neurological adverse reactions in patients with schizophrenia treated with antipsychotics (APs), drug-induced parkinsonism (DIP) is the most common motility disorder caused by drugs affecting dopamine receptors. One of the causes of DIP is the
Externí odkaz:
https://doaj.org/article/b67c295ff17d414c9a4acd8c401493e2
Autor:
Regina F. Nasyrova, Aiperi K. Khasanova, Kuanysh S. Altynbekov, Azat R. Asadullin, Ekaterina A. Markina, Arseny J. Gayduk, German A. Shipulin, Marina M. Petrova, Natalia A. Shnayder
Publikováno v:
Nutrients. 14(23)
Schizophrenia (Sch) is a severe and widespread mental disorder. Antipsychotics (APs) of the first and new generations as the first-line treatment of Sch are not effective in about a third of cases and are also unable to treat negative symptoms and co
Autor:
Arseny J, Gayduk, Tatiana I, Shishkovskaia, Paul, Cumming, Theodoros, Koutsomitros, Alexander T, Sack, Yan V, Vlasov, Daria, Smirnova
Publikováno v:
Psychiatria Danubina. 34(Suppl 8)
Neuropathic pain (NP) affects approximately 7% of the general population and is often accompanied by depressive symptoms with up to 85% of NP patients are suffering from comorbid depression (CD). The noninvasive neuromodulation technique of transcran
Publikováno v:
Psychiatria Danubina. 34(Suppl 8)
rTMS is an adequately safe intervention that is approved for treatment of various neuropsychiatric conditions. There is ongoing research on the application of rTMS for the treatment of resistant auditory verbal hallucinations (AVH) in schizophrenia (